News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
GE Healthcare Completes Acquisition of Vital Signs Inc., Expanding GE’s Monitoring, Anesthesia and Respiratory Care Offerings
October 30, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CHALFONT ST. GILES, England & TOTOWA, N.J.--(BUSINESS WIRE)--GE Healthcare, a unit of General Electric Company (NYSE:GE) announced today the completion of the acquisition of Vital Signs (NASDAQ:VITL).
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
MORE ON THIS TOPIC
Artificial intelligence
AstraZeneca bulks up MASH, cardio work in up to $1.5B AI partnership with insitro
October 15, 2026
·
1 min read
·
Annalee Armstrong
Deals
Stoffels strikes up new biotech in return to Galapagos cell therapy mission
October 15, 2026
·
4 min read
·
Annalee Armstrong
Licensing
Gilead snags equity stake in Vir with up to $1.87B deal for three T cell engagers
October 14, 2026
·
1 min read
·
Annalee Armstrong
Obesity
Zealand pens up to $1.2B deal with Generate for AI-designed obesity, metabolic drugs
October 14, 2026
·
3 min read
·
Tristan Manalac